These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 11108954)

  • 1. The biology of the receptor for advanced glycation end products and its ligands.
    Schmidt AM; Yan SD; Yan SF; Stern DM
    Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
    Stern DM; Yan SD; Yan SF; Schmidt AM
    Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.
    Stern D; Yan SD; Yan SF; Schmidt AM
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1615-25. PubMed ID: 12453678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
    Schmidt AM; Yan SD; Wautier JL; Stern D
    Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE: a multi-ligand receptor unveiling novel insights in health and disease.
    Alexiou P; Chatzopoulou M; Pegklidou K; Demopoulos VJ
    Curr Med Chem; 2010; 17(21):2232-52. PubMed ID: 20459381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
    Lue LF; Yan SD; Stern DM; Walker DG
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
    Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
    Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
    Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression.
    Kislinger T; Fu C; Huber B; Qu W; Taguchi A; Du Yan S; Hofmann M; Yan SF; Pischetsrieder M; Stern D; Schmidt AM
    J Biol Chem; 1999 Oct; 274(44):31740-9. PubMed ID: 10531386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAGE: a novel target for drug intervention in diabetic vascular disease.
    Hudson BI; Schmidt AM
    Pharm Res; 2004 Jul; 21(7):1079-86. PubMed ID: 15290845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease.
    Bucciarelli LG; Wendt T; Rong L; Lalla E; Hofmann MA; Goova MT; Taguchi A; Yan SF; Yan SD; Stern DM; Schmidt AM
    Cell Mol Life Sci; 2002 Jul; 59(7):1117-28. PubMed ID: 12222959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.
    Schmidt AM; Stern DM
    Front Biosci; 2001 Oct; 6():D1151-60. PubMed ID: 11578972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation.
    Schmidt AM; Hofmann M; Taguchi A; Yan SD; Stern DM
    Semin Thromb Hemost; 2000; 26(5):485-93. PubMed ID: 11129404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.
    Wendt T; Tanji N; Guo J; Hudson BI; Bierhaus A; Ramasamy R; Arnold B; Nawroth PP; Yan SF; D'Agati V; Schmidt AM
    J Am Soc Nephrol; 2003 May; 14(5):1383-95. PubMed ID: 12707408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities.
    Lalla E; Lamster IB; Stern DM; Schmidt AM
    Ann Periodontol; 2001 Dec; 6(1):113-8. PubMed ID: 11887453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
    Hori O; Brett J; Slattery T; Cao R; Zhang J; Chen JX; Nagashima M; Lundh ER; Vijay S; Nitecki D
    J Biol Chem; 1995 Oct; 270(43):25752-61. PubMed ID: 7592757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
    Yan SF; Ramasamy R; Schmidt AM
    J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAGE: a novel cellular receptor for advanced glycation end products.
    Schmidt AM; Hori O; Cao R; Yan SD; Brett J; Wautier JL; Ogawa S; Kuwabara K; Matsumoto M; Stern D
    Diabetes; 1996 Jul; 45 Suppl 3():S77-80. PubMed ID: 8674899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
    Basta G
    Atherosclerosis; 2008 Jan; 196(1):9-21. PubMed ID: 17826783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.